| Cost-Effectiveness Analysis of Trastuzumab Deruxtecan versus Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer in the USA | | |
| Cost-Effectiveness of Pembrolizumab for the first line treatment of recurrent or metastatic head and neck squamous cell carcinoma in the United States | Journal of Medical Economics | |
| Operative Versus Nonoperative Management of Displaced Midshaft Clavicle Fractures: A Cost-effectiveness Analysis | Orthopedics | |
| Platelet-Rich Plasma Versus Corticosteroid Injections for the Treatment of Mild-to-Moderate Carpal Tunnel Syndrome: A Markov Cost-Effectiveness Decision Analysis | Hand | |
| Presentation_1.pdf | | 2020 |
| Cost-effectiveness of axicabtagene ciloleucel versus lisocabtagene maraleucel for adult patients with relapsed or refractory large B-cell lymphoma after 2 or more lines of systemic therapy in the US. | Journal of Medical Economics | 2022 |
| Endoscopic Screening Program for Control of Esophageal Adenocarcinoma in Varied Populations: A Comparative Cost-Effectiveness Analysis. | Gastroenterology | 2022 |
| Cost of Hepatitis C care facilitation for HIV/Hepatitis C Co-infected people who use drugs. | Drug and Alcohol Dependence | 2022 |
| An economic evaluation of reducing colorectal cancer surveillance intensity. | Journal of Comparative Effectiveness Research | 2021 |
| SPECT/CT versus planar imaging to determine treatment strategy for non-small-cell lung cancer: a cost-effectiveness analysis. | Journal of Comparative Effectiveness Research | 2022 |
| Cost and Treatment Characteristics of Sport-Related Knee Injuries Managed by Athletic Trainers: A Report From the Athletic Training Practice-Based Research Network | Journal of Athletic Training | 2021 |
| Cost-effectiveness analysis of pembrolizumab plus chemotherapy as first-line therapy for extensive-stage small-cell lung cancer | PLoS ONE | 2021 |
| Patient, Treatment, and Cost Characteristics Associated With Sport-Related Ankle Sprains: A Report From the Athletic Training Practice-Based Research Network | Athletic Training & Sports Health Care | 2020 |
| Cost-Effectiveness of Ipilimumab Plus Anti-PD-1 Therapy Ipilimumab Alone in Patients With Metastatic Melanoma Resistant to Anti-PD-(L)1 Monotherapy | Frontiers in Oncology | 2021 |
| Compensation Rates for Otolaryngologic Procedures Under the Medicare Physician Fee Schedule in 2018 | Laryngoscope | 2021 |
| Whole Slide Image Analysis | | 2022 |
| The Clinical and Financial Cost of SAMS | Contemporary Cardiology | 2020 |
| Imaging for Preoperative Assessment and Staging of Thyroid Cancer | | 2016 |
| Cost-Effectiveness of Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma in the United States | Advances in Therapy | 2021 |
| Operational Impacts of the Coronavirus Disease 2019 (COVID-19) Pandemic and Early Recovery Trends: University of Washington Anatomic Pathology Experience | Archives of Pathology and Laboratory Medicine | 2021 |
| Ambulatory surgery center utilization by vitreoretinal surgeons: 1999-2011 | Ophthalmic Surgery Lasers and Imaging Retina | 2015 |
| Cost effectiveness analysis comparing repetitive transcranial magnetic stimulation to antidepressant medications after a first treatment failure for major depressive disorder in newly diagnosed patients - A lifetime analysis | PLoS ONE | 2017 |
| Economic Evaluation of Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure With Reduced Ejection Fraction | Circulation: Cardiovascular Quality and Outcomes | 2020 |
| Estimation of total costs in patients with relapsed or refractory diffuse large B-cell lymphoma receiving tisagenlecleucel from a US hospital's perspective | Journal of Medical Economics | 2020 |
| Budget impact of capmatinib for adults with metastatic non-small cell lung cancer harboring a exon 14 skipping mutation in the United States | Journal of Medical Economics | 2021 |
| Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab for Advanced Non-Small-Cell Lung Cancer | Frontiers in Pharmacology | 2021 |
| Telemedicine for Children With Medical Complexity: A Randomized Clinical Trial | Pediatrics | 2021 |
| The Economics of Using Locally Ablative Therapy in Oligometastatic Cancer | Seminars in Radiation Oncology | 2021 |
| Modelling the cost effectiveness of non-alcoholic fatty liver disease risk stratification strategies in the community setting | PLoS ONE | 2021 |
| Cost-Effectiveness of Adding Ribociclib to Endocrine Therapy for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer Among Premenopausal or Perimenopausal Women | Frontiers in Oncology | 2021 |
| Preterm birth lifetime costs in the United States in 2016: An update | Seminars in Perinatology | 2021 |
| Opportunities to Reduce Potential Bias in Ophthalmic Cost-Utility Analysis | JAMA Ophthalmology | 2021 |
| An assessment of prevalence and expenditure associated with discharge brain MRI in preterm infants | PLoS ONE | 2021 |
| Social and economic cost of eating disorders in the United States: Evidence to inform policy action | International Journal of Eating Disorders | 2021 |
| Nerve biopsy: Current indications and decision tools | Muscle and Nerve | 2021 |
| The potential public health and economic value of a hypothetical COVID-19 vaccine in the United States: Use of cost-effectiveness modeling to inform vaccination prioritization | Vaccine | 2021 |
| Hospital Consultation From Outpatient Clinicians for Medically Complex Children: A Randomized Clinical Trial | JAMA Pediatrics | 2021 |
| Real-world cost-effectiveness of stool-based colorectal cancer screening in a Medicare population | Journal of Medical Economics | 2021 |
| Cost effectiveness of axicabtagene ciloleucel versus tisagenlecleucel for adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy in the United States | Journal of Medical Economics | 2021 |
| Financial Reimbursement and Enteral Access | Current Surgery Reports | 2021 |
| Cost-effectiveness of topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis | Journal of Medical Economics | 2021 |
| Budget Impact of Oral Semaglutide Intensification versus Sitagliptin among US Patients with Type 2 Diabetes Mellitus Uncontrolled with Metformin | Pharmacoeconomics | 2021 |
| COVID-19 polymerase chain reaction testing before endoscopy: an economic analysis | Gastrointestinal Endoscopy | 2020 |
| Medicare for All: Considerations for Neuroradiologists | American Journal of Neuroradiology | 2020 |
| Cost-effectiveness of pembrolizumab for advanced non-small cell lung cancer patients with varying comorbidity burden | PLoS ONE | 2020 |
| Cost-Utility of Antimicrobial Prophylaxis for Treatment of Children With Vesicoureteral Reflux | Frontiers in Pediatrics | 2019 |
| Index and follow-up costs of endovascular abdominal aortic aneurysm repair from the Endurant Stent Graft System Post Approval Study (ENGAGE PAS) | Journal of Vascular Surgery | 2020 |
| A budget impact analysis for making treatment decisions based on anti-cyclic citrullinated peptide (anti-CCP) testing in rheumatoid arthritis | Journal of Medical Economics | 2020 |
| Contextualizing Medicaid reimbursement rates for abortion procedures | Contraception | 2020 |
| Cost-Consequence Analysis of Mobile Stroke Units vs. Standard Prehospital Care and Transport | Frontiers in Neurology | 2019 |
